{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:11:19Z","timestamp":1791101479210,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":5108,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.fertnstert.2008.02.092","type":"journal-article","created":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T04:07:40Z","timestamp":1212293260000},"page":"1595-1602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Drugs in infertility and fetal safety"],"prefix":"10.1016","volume":"89","author":[{"given":"Shai E.","family":"Elizur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Togas","family":"Tulandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2008.02.092_bib1","series-title":"Williams obstetrics","year":"2005"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.siny.2004.09.015","article-title":"Effects of drugs on the fetus","volume":"10","author":"Jacqz-Aigrain","year":"2005","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0015-0282(16)48069-6","article-title":"Clomiphene citrate: mechanism(s) and site(s) of action\u2014a hypothesis revisited","volume":"42","author":"Adashi","year":"1984","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1095\/biolreprod25.3.667","article-title":"Agonistic and antagonistic effects of clomiphene citrate and its isomers","volume":"25","author":"Clark","year":"1981","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0015-0282(16)49574-9","article-title":"Single-dose pharmacokinetics of clomiphene citrate in normal volunteers","volume":"46","author":"Mikkelson","year":"1986","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0015-0282(98)00537-8","article-title":"Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women","volume":"71","author":"Young","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0015-0282(16)49396-9","article-title":"Effect of clomiphene citrate on in vitro ovulated ova","volume":"45","author":"Yoshimura","year":"1986","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib8","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(89)91892-8","article-title":"Ovulation induction and neural tube defects","volume":"2","author":"Cuckle","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0890-6238(95)00028-9","article-title":"Clomiphene-induced ovulation and the risk of neural tube defects","volume":"9","author":"Lammer","year":"1995","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0015-0282(16)57905-9","article-title":"Clomiphene citrate and neural tube defects: a pooled analysis of controlled epidemiologic studies and recommendations for future studies","volume":"64","author":"Greenland","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.900","article-title":"The use of drugs in mothers of offspring with neural-tube defects","volume":"13","author":"Medveczky","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib12","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/bdra.20313","article-title":"Potential association between infertility and spinal neural tube defects in offspring","volume":"76","author":"Wu","year":"2006","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/09513590400007234","article-title":"Pregnancy outcomes with increased clomiphene citrate dose","volume":"19","author":"Jain","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib14","series-title":"Hormones and cancer","article-title":"Effect of clomiphene and other triphenylethylene derivativs on the reproductive tract in the rat and baboon","author":"Clark","year":"1980"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib15","series-title":"Estrogen in the environment","article-title":"Estrogen, anti-estrogen and regulation of cell proliferation in the female reproductive tract in vivo","author":"Martin","year":"1980"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/tcm.1010","article-title":"Oral administration of clomiphene to neonatal rats causes reproductive tract abnormalities","volume":"21","author":"Nagao","year":"2001","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib17","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0140-6736(02)08152-7","article-title":"Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study","volume":"359","author":"Klip","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/bmj.38326.606979.79","article-title":"Use of clomifene during early pregnancy and risk of hypospadias: population based case\u2013control study","volume":"330","author":"Sorensen","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/bdra.20243","article-title":"Clomiphene and hypospadias on a detailed level: signal or chance?","volume":"76","author":"Meijer","year":"2006","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib20","first-page":"10","article-title":"Aromatase inhibitors and breast cancer","volume":"23","author":"Brodie","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.fertnstert.2005.05.078","article-title":"A new era in ovulation induction","volume":"85","author":"Holzer","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2004-823028","article-title":"Aromatase inhibitors in ovulation induction","volume":"22","author":"Mitwally","year":"2004","journal-title":"Semin Reprod Med"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2008.02.092_bib23","doi-asserted-by":"crossref","first-page":"s95","DOI":"10.1016\/j.fertnstert.2005.07.230","article-title":"The outcome of 150 babies following the treatment with letrozole and gonadotropins","volume":"84","author":"Biljan","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib24","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","article-title":"Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate","volume":"85","author":"Tulandi","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ajog.2004.08.013","article-title":"Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation","volume":"192","author":"Mitwally","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1701-2163(16)32551-8","article-title":"Fetal safety of letrozole and clomiphene citrate for ovulation induction","volume":"29","author":"Forman","year":"2007","journal-title":"J Obstet Gynecol Can"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00006254-200211000-00022","article-title":"New approach to polycystic ovary syndrome and other forms of anovulatory infertility","volume":"57","author":"Laven","year":"2002","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2337\/diacare.15.6.755","article-title":"Biguanides and NIDDM","volume":"15","author":"Bailey","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/diacare.13.6.696","article-title":"Cellular mechanism of action of metformin","volume":"13","author":"Klip","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib31","first-page":"69","article-title":"Insulin, glibenclamide or metformin treatment for non insulin dependent diabetes: heterogenous responses of standard measures of insulin action and insulin secretion before and after differing hypoglycaemic therapy","volume":"19","author":"Boyd","year":"1992","journal-title":"Diabetes Res"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejogrb.2003.11.027","article-title":"Insulin resistance and metformin in polycystic ovary syndrome","volume":"115","author":"Ben-Haroush","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib34","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0015-0282(00)01666-6","article-title":"Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study","volume":"75","author":"Glueck","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib37","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.fertnstert.2005.09.047","article-title":"Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin","volume":"85","author":"Thatcher","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib39","first-page":"307","article-title":"Congenital malformations in infants of 517 pregestational diabetic mothers","volume":"33","author":"Botta","year":"1997","journal-title":"Ann Ist Super Sanita"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib40","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2337\/diacare.18.11.1446","article-title":"Congenital malformations in pregnancies complicated by NIDDM","volume":"18","author":"Towner","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/tera.1420490405","article-title":"Effects of the biguanide class of oral hypoglycemic agents on mouse embryogenesis","volume":"49","author":"Denno","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib42","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.fertnstert.2006.02.098","article-title":"Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis","volume":"86","author":"Gilbert","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib43","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jcem-18-12-1333","article-title":"Clinical effect of human pituitary follicle-stimulating hormone (FSH)","volume":"18","author":"Gamzell","year":"1958","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl","key":"10.1016\/j.fertnstert.2008.02.092_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00016347509158675","article-title":"Induction of ovulation","volume":"47","author":"Gamzell","year":"1975","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib45","series-title":"Human pituitary gonadotropins","article-title":"Pharmacologic and clinial effects of a gonadotropin preparation from human post menopausal urine","author":"Borth","year":"1961"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib46","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0140-6736(76)90921-1","article-title":"Ovulation induction and congenital malformation","volume":"1","author":"Harlap","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(16)54048-5","article-title":"Early miscarriage and fetal malformations after induction of ovulation (by clomiphene citrate and\/or human menotropins), in vitro fertilization, and gamete intrafallopian transfer","volume":"55","author":"Shoham","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib48","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0002-9378(58)90722-1","article-title":"Fertility control with oral medication","volume":"75","author":"Pincus","year":"1958","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib49","series-title":"Progesterone","article-title":"Progesterone and related steroids in the managment of abortions","author":"Kupperman","year":"1961"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib50","first-page":"2757","article-title":"Physiologie und Pathologie der Sexualhormone, im Besonderen des Hormones des Corpus luteum. I. Der biologische Test fur Das Luteumhormon (das spezielle Hormon des Corpus luteum) am infantilen Kaninchen","volume":"54","author":"Clauberg","year":"1930","journal-title":"Z Gynakol Leipzig"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13625180600772741","article-title":"Metabolic and clinical effects of progestogens","volume":"11","author":"Wiegratz","year":"2006","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0149-2918(00)88267-3","article-title":"Oral micronized progesterone","volume":"21","author":"de Lignieres","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib53","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humrep\/17.2.357","article-title":"Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial","volume":"17","author":"Nyboe Andersen","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1095\/biolreprod15.1.84","article-title":"Effects of maternal progesterone supplementation on fetal, placental and corpus luteal weights in the rat","volume":"15","author":"Bartholomeusz","year":"1976","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/tera.1420270109","article-title":"Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations","volume":"27","author":"Michaelis","year":"1983","journal-title":"Teratology"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib56","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0015-0282(16)48490-6","article-title":"Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936\u20131974","volume":"43","author":"Resseguie","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0015-0282(16)48670-X","article-title":"Fetal malformations following progesterone therapy during pregnancy: a preliminary report","volume":"44","author":"Rock","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0015-0282(16)49292-7","article-title":"The risk of fetal anomalies as a result of progesterone therapy during pregnancy","volume":"45","author":"Check","year":"1986","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib59","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF00144810","article-title":"An international case\u2013control study on hypospadias. The problem with variability and the beauty of diversity","volume":"8","author":"Kallen","year":"1992","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JRS-1992-3402","article-title":"Hormone therapy during pregnancy and isolated hypospadias: an international case\u2013control study","volume":"3","author":"Kallen","year":"1992","journal-title":"Int J Risk Saf Med"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib61","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archpedi.159.10.957","article-title":"Maternal progestin intake and risk of hypospadias","volume":"159","author":"Carmichael","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib62","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/bdra.20184","article-title":"Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation","volume":"73","author":"Brent","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0010-7824(02)00340-2","article-title":"Pregnancies diagnosed during Depo-Provera use","volume":"66","author":"Borgatta","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib64","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3181\/00379727-97-23885","article-title":"Influence of female sex hormones in experimental teratogenesis","volume":"97","author":"Nishihara","year":"1958","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib65","series-title":"Chemically induced birth defects","author":"Schardein","year":"2000"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/tera.1420350116","article-title":"Embryotoxicity of sex steroidal hormones in nonhuman primates: II. Hydroxyprogesterone caproate, estradiol valerate","volume":"35","author":"Hendrickx","year":"1987","journal-title":"Teratology"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib67","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/00016347609156917","article-title":"A prospective study of drugs and pregnancy. 3","volume":"55","author":"Kullander","year":"1976","journal-title":"Hormones. Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib68","series-title":"Birth defects and drugs in pregnancy","author":"Heinonen","year":"1977"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib69","first-page":"552","article-title":"Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies","volume":"76","author":"Bracken","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0029-7844(94)00341-A","article-title":"Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis","volume":"85","author":"Raman-Wilms","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib71","first-page":"665","article-title":"Teratogenicity study of subcutaneously administered buserelin acetate in rabbits","volume":"33","author":"Akaike","year":"1987","journal-title":"Oyo Yakuri"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib72","first-page":"257","article-title":"Effect on mouse fetuses of HOE 766 microparticles administered subcutaneously to maternal animals on Day 0 of gestation","volume":"24","author":"Akaike","year":"1996","journal-title":"Yakuri to Chiryo"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib73","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/oxfordjournals.humrep.a137830","article-title":"Exposure to LHRH agonists in early pregnancy following the commencement of mid-luteal buserelin for IVF stimulation","volume":"7","author":"Jackson","year":"1992","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib74","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0015-0282(16)55702-1","article-title":"Pregnancy during long-term gonadotropin-releasing hormone agonist therapy associated with clinical pseudomenopause","volume":"59","author":"Har-Toov","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib75","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0015-0282(00)01524-7","article-title":"Should we still advise infertile couples to use (barrier) contraception before IVF down-regulation?","volume":"74","author":"Platteau","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib76","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0015-0282(16)57557-8","article-title":"Administration of a gonadotropin-releasing hormone agonist during pregnancy: follow-up of 28 pregnancies exposed to triptoreline","volume":"63","author":"Elefant","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib77","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1093\/humrep\/14.10.2656","article-title":"Long-term follow-up of children born after inadvertent administration of a gonadotrophin-releasing hormone agonist in early pregnancy","volume":"14","author":"Lahat","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib78","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0015-0282(00)01632-0","article-title":"Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix","volume":"75","author":"Ludwig","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib79","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/16.8.1588","article-title":"Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report","volume":"16","author":"Olivennes","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib80","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/humrep\/17.8.2027","article-title":"Obstetrical and neonatal outcome after controlled ovarian stimulation for IVF using the GnRH antagonist ganirelix","volume":"17","author":"Boerrigter","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.02.092_bib81","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/bmj.38919.495718.AE","article-title":"Infertility, infertility treatment, and congenital malformations: Danish national birth cohort","volume":"333","author":"Zhu","year":"2006","journal-title":"BMJ"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208003592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208003592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:23:55Z","timestamp":1758007435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028208003592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0015028208003592"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.02.092","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drugs in infertility and fetal safety","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.02.092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}